Komori
Business alliance197ATAUNS Laboratories,Inc.Pharmaceuticals

Notice of a Basic Agreement on a Capital and Business Alliance with カリスト株式会社

タウンズ has reached a basic agreement on a capital and business alliance under which it will subscribe for common shares issued by カリスト株式会社. The two companies will work to build a data bank and AI analysis environment that will facilitate the use of medical data for research and development.

Worth reading
50Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Agreements reached under this partnership

Capital and Business Alliance
197ATAUNS Laboratories,Inc.
Alliance partnerカリスト株式会社
Details of the alliance
  1. 1

    We will promote the construction of a medical data bank by preparing and integrating specimen information, medical images and clinical information, including electronic medical records, in a format suitable for R&D while complying with applicable laws and regulations and giving full consideration to ethics and information security.

  2. 2

    In addition, the companies will develop an operating environment, including computing resources and an AI analysis environment, to support the advanced use of medical data.

These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.

Capital and personnel relationships

This indicates whether the companies will do more than work together, such as holding each other’s shares or seconding personnel (capital and business alliance).

Acquisition priceNot disclosed
About the partner
Business DescriptionDevelopment of medical data infrastructure for medical AI and clinical research / Contract development and technology consulting for drug discovery AI and medical AI
LocationShinjuku-ku, Tokyo
Impact on Business Performance

At this time, we expect this basic agreement to have a limited impact on the company's near-term results. If it becomes clear that the agreement will have a material impact, we will disclose the information promptly.

Agreements reached under this partnership
ItemDetails
Name of alliance partnerカリスト株式会社
Alliance partner's business activitiesDevelopment of medical data infrastructure for medical AI and clinical research, Contract development and technology consulting for drug discovery AI and medical AI
Alliance partner's locationShinjuku-ku, Tokyo
Type of allianceCapital and Business Alliance
Details of the allianceWe will promote the construction of a medical data bank by preparing and integrating specimen information, medical images and clinical information, including electronic medical records, in a format suitable for R&D while complying with applicable laws and regulations and giving full consideration to ethics and information security., In addition, the companies will develop an operating environment, including computing resources and an AI analysis environment, to support the advanced use of medical data.
Acquisition priceNot disclosed
Impact on Business PerformanceAt this time, we expect this basic agreement to have a limited impact on the company's near-term results. If it becomes clear that the agreement will have a material impact, we will disclose the information promptly.
Items this document does not state (16)
Alliance partner's capitalAlliance partner's net salesAlliance partner's operating incomeNumber of shares acquiredShareholding ratioOverview of the joint ventureOwnership ratioDispatch of directors and officersContract PeriodNumerical targets under the allianceShareholding PolicyDate of board resolutionContract DateAlliance start dateShare Acquisition Date and Payment DateChange in major shareholders

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To combine カリスト株式会社’s technologies for acquiring, processing and analyzing medical data and its business platform with タウンズ’s diagnostic technologies and network of medical institutions, with the aim of creating value through the effective use of medical data and addressing social issues.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of a Basic Agreement on a Capital and Business Alliance with カリスト株式会社 | TAUNS Laboratories,Inc. (197A) timely disclosure | Komori